Comment from Pharmaceutical Research and Manufacturers of America (PhRMA)

Summary: The Pharmaceutical Research and Manufacturers of America (PhRMA) supports the FDA's Draft Guidance on New Approach Methodologies (NAMs) as a step toward reducing animal testing in drug development. They request specific revisions to clarify validation frameworks, enhance transparency through a centralized database, and provide more detailed examples across different therapeutic modalities.